Treatment of the idiopathic inflammatory myopathies: A retrospective analysis of 63 Caucasian patients longitudinally followed at a single center
M. Mosca1, R. Neri2, G. Pasero2, S. Bombardieri1
1Clinical Immunology Unit and 2Rheumatology Unit, Department of Internal Medicine, University of Pisa, Italy.
ABSTRACT
Objective
To analyze the therapies used over the past 20 years at a single center to treat patients with idiopathic inflammatory myopathies (IIM), and to compare their effectiveness.
Methods
Sixty-three Caucasian IIM patients were selected for this
study based on the following parameters: (i) a definite diagnosis of IIM; (ii) a follow-up period of
at least one year; and (iii) a complete record of clinical and
serological data for the course of the follow-up. The following
data were collected from the patients' records: the first choice
and subsequent therapies, the patient's response to these
treatments, the outcome at the end of the follow-up.
Results
Two therapeutic approaches were identified: steroids alone
and the combination of steroids with immunosuppressive drugs. Of the 63 patients studied, 36
received steroids alone and 27 received steroids plus
immunosuppressors. Sixteen patients did not respond to the
initial therapy, 33 showed a stable response, and 14 experienced
a relapse in disease activity during the follow-up. No
statistically significant differences among these 3 groups of
patients were observed with respect to sex, age at disease onset,
diagnosis, CPK levels at disease onset, and therapeutic approach.
Conclusion
Corticosteroids represent the mainstay of IIM therapy, both
as the first choice treatment and as maintenance therapy. The use of immunosuppressive agents
should be restricted to those patients with severe
contraindications to steroid treatment.
Keywords
Idiopathic inflammatory myopathies, therapy, corticosteroids,
immunosuppressive drugs.
Please address correspondence and reprint requests to: M.
Mosca, M.D., Clinical Immunology Unit, Department of Internal
Medicine, University of Pisa, via Roma 67, 56126 Pisa, Italy.
E-mail: marta@sssup.it
Clinical and Experimental Rheumatology 2000; 18:
451-456.
© Copyright Clinical and Experimental
Rheumatology 2000.